» Articles » PMID: 25761716

Mechanisms of Programmed Cell Death Signaling in Hair Cells and Support Cells Post-electrode Insertion Trauma

Overview
Date 2015 Mar 13
PMID 25761716
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Conclusion: Programmed cell death (PCD) initially starts in the support cells (SCs) after electrode insertion trauma (EIT), followed by PCD in hair cells (HCs). Activation of caspase-3 was observed only in SCs. Protecting both SCs and HCs with selective otoprotective drugs at an early stage post implantation may help to preserve residual hearing.

Objectives: Cochlear implant EIT can initiate sensory cell losses via necrosis and PCD within the organ of Corti, which can lead to a loss of residual hearing. PCD appears to be a major factor in HC loss post-EIT. The current study aimed to: (1) determine the onset of PCD in both SCs and HCs within the traumatized organ of Corti; and (2) identify the molecular mechanisms active within the HCs and SCs that are undergoing PCD.

Methods: Adult guinea pigs were assigned to one of two groups: (1) EIT and (2) unoperated contralateral ears as controls. Immunostaining of dissected organ of Corti surface preparations for phosphorylated-Jun, cleaved caspase-3, and 4-hydroxy-2,3-nonenal (HNE) were performed at 6, 12, and 24 h post-EIT and for contralateral control ears.

Results: At 6 h post-EIT the SCs immunolabeled for the presence of phosphorylated-Jun and activated caspase-3. Phosphorylated p-Jun labeling was observed at 12 h in both the HCs and SCs of middle and basal cochlear turns. Cleaved caspase-3 was not observed in HCs of any cochlear turn at up to 24 h post-EIT. Lipid peroxidation (HNE immunostaining) was first observed at 12 h post-EIT in both the HCs and SCs of the basal turn, and reached the apical turn by 24 h post-EIT.

Citing Articles

A preoperative dose of the pyridoindole AC102 improves the recovery of residual hearing in a gerbil animal model of cochlear implantation.

Nieratschker M, Yildiz E, Gerlitz M, Bera S, Gadenstaetter A, Kramer A Cell Death Dis. 2024; 15(7):531.

PMID: 39060244 PMC: 11282255. DOI: 10.1038/s41419-024-06854-9.


Intra-Cochlear Electrode Position Impacts the Preservation of Residual Hearing in an Animal Model of Cochlear Implant Surgery.

Meuser M, Schwitzer S, Thiele M, Boyle P, Ernst A, Basta D Audiol Neurootol. 2024; 30(1):34-44.

PMID: 38981457 PMC: 11809461. DOI: 10.1159/000540266.


Outcomes following cochlear implantation with eluting electrodes: A systematic review.

Fleet A, Nikookam Y, Radotra A, Gowrishankar S, Metcalfe C, Muzaffar J Laryngoscope Investig Otolaryngol. 2024; 9(3):e1263.

PMID: 38855776 PMC: 11160184. DOI: 10.1002/lio2.1263.


Delayed hearing loss after cochlear implantation: Re-evaluating the role of hair cell degeneration.

OMalley J, Wu P, Kaur C, Gantz B, Hansen M, Quesnel A Hear Res. 2024; 447:109024.

PMID: 38735179 PMC: 11134194. DOI: 10.1016/j.heares.2024.109024.


Neuroprotection and Neuroregeneration Strategies Using the rNAION Model: Theory, Histology, Problems, Results and Analytical Approaches.

Bernstein S, Guo Y, Mehrabian Z, Miller N Int J Mol Sci. 2022; 23(24).

PMID: 36555246 PMC: 9778957. DOI: 10.3390/ijms232415604.